Insights
News
MediaBrainSightAI Unveils Groundbreaking AI/ML Platform at CES 2024
BrainSightAI, a pioneering neurotech firm, has taken the stage at the Consumer Electronics Show (CES) 2024 to introduce its innovative artificial intelligence/machine learning (AI/ML) platform, accompanied by the Virtual Twin Evolution. In partnership with Dassault Systèmes and the 3DEXPERIENCE Lab, BrainSightAI has ushered in a remarkable transformation in the realm of neurological and psychiatric diagnosis and prognosis.
Revolutionary AI/ML platform enhancing brain analysis
BrainSightAI’s groundbreaking AI/ML platform, unveiled at CES 2024, leverages advanced connectomic analysis on brain MRI images. This cutting-edge technology enables the creation of intricate structural and functional brain maps, offering healthcare professionals unprecedented insights for more precise patient diagnosis and prognosis.
Collaboration with dassault systèmes drives innovation
This monumental achievement is a result of BrainSightAI’s collaboration with Dassault Systèmes. Employing Dassault Systèmes’ advanced tools, including the 3DEXPERIENCE Platform and Medidata Platform apps such as Rave EDC, BrainSightAI has streamlined clinical trial data capture and management. This fusion of medical insights with efficient clinical trial management marks a significant milestone in patient care and research.
A leap toward global healthcare solutions
Frederic Vacher, Head of Innovation at 3DEXPERIENCE Lab, commended the lab’s role in accelerating disruptive innovations with the potential for positive societal impact. Laina Emmanuel, CEO of BrainSightAI, underscored the company’s commitment to developing tools capable of deciphering the intricate network of neurons within the brain. Suhaspritipal Gongate, from 3DEXPERIENCE Lab DASSAULT SYSTEMES India, emphasized BrainSightAI’s role in addressing global healthcare challenges through brain mapping and AI.
Leadership in medical innovation from Bangalore
Based in Bangalore, BrainSightAI is dedicated to the development of AI-enabled applications designed to assist neurosurgeons, psychiatrists, and neurologists in their treatments and provide digital support to patients. This comprehensive suite of applications firmly establishes BrainSightAI as a trailblazer in medical innovation. Dassault Systèmes continues its support of startups like BrainSightAI through its 3DEXPERIENCE Lab program, offering mentorship and valuable resources.
Advanced connectomic analysis for precise diagnoses
BrainSightAI’s AI/ML platform leverages advanced connectomic analysis techniques on brain MRI images. This groundbreaking approach allows for the creation of highly detailed structural and functional brain maps. These maps provide healthcare professionals with unparalleled insights into the intricacies of the brain’s structure and function, facilitating more accurate and precise diagnoses of neurological and psychiatric conditions.
Collaboration with dassault systèmes streamlines clinical trials
The collaboration between BrainSightAI and Dassault Systèmes has yielded remarkable results in the field of healthcare innovation. Dassault Systèmes’ cutting-edge tools, including the 3DEXPERIENCE Platform and Medidata Platform apps like Rave EDC, have played a pivotal role in streamlining the capture and management of clinical trial data. This integration of medical insights with efficient clinical trial management not only expedites the research process but also enhances the quality of patient care.
Global impact through brain mapping and AI
BrainSightAI’s partnership with Dassault Systèmes reflects a commitment to addressing global healthcare challenges. By combining the power of brain mapping and AI, BrainSightAI aims to provide solutions that can revolutionize the diagnosis and treatment of neurological and psychiatric disorders on a global scale. The collaboration between BrainSightAI and 3DEXPERIENCE Lab DASSAULT SYSTEMES India underscores the potential for positive societal impact through these innovative technologies.
A trailblazer in medical innovation
Located in Bangalore, BrainSightAI has emerged as a leader in medical innovation. The company’s suite of AI-enabled applications is designed to assist healthcare professionals in their efforts to improve patient outcomes. Neurosurgeons, psychiatrists, and neurologists can benefit from these applications, which harness the power of AI to enhance diagnosis and treatment. BrainSightAI’s dedication to advancing medical technology aligns perfectly with Dassault Systèmes’ mission to support and mentor startups through its 3DEXPERIENCE Lab program.
Read More
BrainSightAI Unveils Groundbreaking AI/ML Platform at CES 2024
BrainSightAI, a pioneering neurotech firm, has taken the stage at the Consumer Electronics Show (CES) 2024 to introduce its innovative artificial intelligence/machine learning (AI/ML) platform, accompanied by the Virtual Twin Evolution. In partnership with Dassault Systèmes and the 3DEXPERIENCE Lab, BrainSightAI has ushered in a remarkable transformation in the realm of neurological and psychiatric diagnosis and prognosis.
Revolutionary AI/ML platform enhancing brain analysis
BrainSightAI’s groundbreaking AI/ML platform, unveiled at CES 2024, leverages advanced connectomic analysis on brain MRI images. This cutting-edge technology enables the creation of intricate structural and functional brain maps, offering healthcare professionals unprecedented insights for more precise patient diagnosis and prognosis.
Collaboration with dassault systèmes drives innovation
This monumental achievement is a result of BrainSightAI’s collaboration with Dassault Systèmes. Employing Dassault Systèmes’ advanced tools, including the 3DEXPERIENCE Platform and Medidata Platform apps such as Rave EDC, BrainSightAI has streamlined clinical trial data capture and management. This fusion of medical insights with efficient clinical trial management marks a significant milestone in patient care and research.
A leap toward global healthcare solutions
Frederic Vacher, Head of Innovation at 3DEXPERIENCE Lab, commended the lab’s role in accelerating disruptive innovations with the potential for positive societal impact. Laina Emmanuel, CEO of BrainSightAI, underscored the company’s commitment to developing tools capable of deciphering the intricate network of neurons within the brain. Suhaspritipal Gongate, from 3DEXPERIENCE Lab DASSAULT SYSTEMES India, emphasized BrainSightAI’s role in addressing global healthcare challenges through brain mapping and AI.
Leadership in medical innovation from Bangalore
Based in Bangalore, BrainSightAI is dedicated to the development of AI-enabled applications designed to assist neurosurgeons, psychiatrists, and neurologists in their treatments and provide digital support to patients. This comprehensive suite of applications firmly establishes BrainSightAI as a trailblazer in medical innovation. Dassault Systèmes continues its support of startups like BrainSightAI through its 3DEXPERIENCE Lab program, offering mentorship and valuable resources.
Advanced connectomic analysis for precise diagnoses
BrainSightAI’s AI/ML platform leverages advanced connectomic analysis techniques on brain MRI images. This groundbreaking approach allows for the creation of highly detailed structural and functional brain maps. These maps provide healthcare professionals with unparalleled insights into the intricacies of the brain’s structure and function, facilitating more accurate and precise diagnoses of neurological and psychiatric conditions.
Collaboration with dassault systèmes streamlines clinical trials
The collaboration between BrainSightAI and Dassault Systèmes has yielded remarkable results in the field of healthcare innovation. Dassault Systèmes’ cutting-edge tools, including the 3DEXPERIENCE Platform and Medidata Platform apps like Rave EDC, have played a pivotal role in streamlining the capture and management of clinical trial data. This integration of medical insights with efficient clinical trial management not only expedites the research process but also enhances the quality of patient care.
Global impact through brain mapping and AI
BrainSightAI’s partnership with Dassault Systèmes reflects a commitment to addressing global healthcare challenges. By combining the power of brain mapping and AI, BrainSightAI aims to provide solutions that can revolutionize the diagnosis and treatment of neurological and psychiatric disorders on a global scale. The collaboration between BrainSightAI and 3DEXPERIENCE Lab DASSAULT SYSTEMES India underscores the potential for positive societal impact through these innovative technologies.
A trailblazer in medical innovation
Located in Bangalore, BrainSightAI has emerged as a leader in medical innovation. The company’s suite of AI-enabled applications is designed to assist healthcare professionals in their efforts to improve patient outcomes. Neurosurgeons, psychiatrists, and neurologists can benefit from these applications, which harness the power of AI to enhance diagnosis and treatment. BrainSightAI’s dedication to advancing medical technology aligns perfectly with Dassault Systèmes’ mission to support and mentor startups through its 3DEXPERIENCE Lab program.
Read More